Anti-MMP-8 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the hinge region of human MMP-8 (neutrophil collagenase), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
UniProt
P22894
Size
100ug
Cat. #
RP1MMP8

In stock

SKU
RP-MMP8

Options

As low as: $130.00

Target Overview

Matrix metalloproteinase-8 (MMP-8, UniProt P22894), also known as neutrophil collagenase or PMNL collagenase, is a zinc-dependent endopeptidase (EC 3.4.24.34) of the matrixin family. Encoded by the MMP8 gene, this 467-amino acid protein is stored in cytoplasmic granules of neutrophils and released upon degranulation during inflammation. MMP-8 exhibits preferential activity against fibrillar collagens, degrading type I, II, and III collagens—key structural components of the extracellular matrix. Its proteolytic activity is tightly regulated by tissue inhibitors of metalloproteinases (TIMPs) and is activated through cleavage of the N-terminal propeptide domain. Researchers study MMP-8 in contexts ranging from wound healing and tissue remodeling to periodontal disease, cancer metastasis, and inflammatory disorders. The enzyme's specificity for interstitial collagens distinguishes it from other MMPs and makes it a marker of neutrophil activity in both acute and chronic inflammatory conditions.

Background

MMP-8 was originally identified as a product of polymorphonuclear leukocytes and is now recognized as a central mediator of extracellular matrix turnover during immune responses. Beyond its classical role in collagen degradation, MMP-8 cleaves a range of non-matrix substrates including chemokines and growth factors, modulating inflammatory signaling pathways. Unlike some MMPs that promote tumor progression, MMP-8 has been reported to exhibit protective or anti-metastatic properties in certain cancer models, though its role varies by tissue context and tumor microenvironment. Recent investigations have expanded the clinical relevance of MMP-8 measurements. Borikun and colleagues reported stress-induced changes in the methylation status of Mmp8 genes in tumor tissue of rats with Guerin carcinoma, suggesting epigenetic regulation of MMP-8 expression under physiological stress (Exp Oncol 2026; PMID 42290557). Salivary MMP-8 has emerged as a non-invasive biomarker in periodontal and systemic inflammatory conditions. Alhelfi et al demonstrated that salivary inflammatory biomarkers, including MMP-8, correlate with periodontal status in males with nephrolithiasis, highlighting cross-talk between oral and systemic inflammation (Biomed Res Int 2026; PMID 42287034). MMP-8 is also being evaluated in obstetric and sepsis research. Hong and colleagues identified MMP-8 as part of an integrated inflammatory signature associated with vaginal dysbiosis in preterm labor (Front Immunol 2026; PMID 42327783), while Li et al incorporated MMP8 transcriptomic data into diagnostic models for septic shock (Front Immunol 2026; PMID 42266692). These studies underscore MMP-8's utility as both a mechanistic target and a biomarker across diverse inflammatory and pathological states.

References

  1. Hong S et al (2026) Vaginal dysbiosis and inflammatory signatures in preterm labor: an integrated model for predicting preterm birth. Front Immunol. PubMed · DOI
  2. Borikun T (2026) Stress-Induced Changes in the Methylation Status of Mmp1 and Mmp8 Genes in Tumor Tissue of Rats with Guerin Carcinoma. Exp Oncol. PubMed · DOI
  3. Alhelfi NM et al (2026) Salivary Inflammatory Biomarkers in Males With Nephrolithiasis Correlate With Periodontal Status: A Case-Control Study. Biomed Res Int. PubMed · DOI
  4. Mainas G et al (2026) A Fasting-Mimicking Diet Affects the Inflammatory Response Following Periodontal Treatment: A Multi-centre Feasibility Randomised Controlled Pilot Trial. J Clin Periodontol. PubMed · DOI
  5. Li L et al (2026) Multi-cohort transcriptomics integration for building and validating a diagnostic model of peripheral blood septic shock. Front Immunol. PubMed · DOI

Additional Specifications

Gene Symbol MMP8
UniProt ID P22894
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Hinge region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 251-275.
Immunogen (Â Aminoterminal end of active enzyme)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 101-151.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 417-467.
Immunogen (Propeptide region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 21-100.
Alternate Names Neutrophil collagenase, Matrix metalloproteinase-8, MMP-8, PMNL collagenase, PMNL-CL, EC 3.4.24.34, CLG1

Frequently Asked Questions

What molecular weight band should I expect for MMP-8 on Western blot?

Full-length MMP-8 migrates at approximately 75 kDa, corresponding to the proenzyme form (zymogen) typically found in neutrophil granules. Upon activation by proteolytic cleavage of the N-terminal propeptide, you may observe a mature active form around 58–65 kDa. In samples from inflammatory sites or stimulated neutrophils, expect both pro- and active forms. The exact mobility depends on glycosylation state and your gel system. Recombinant MMP-8 standards often resolve near 53 kDa if the propeptide is already removed. Always include a positive control such as activated neutrophil lysate or recombinant MMP-8 to confirm band identity.

Does this antibody recognize both pro-MMP-8 and active MMP-8?

Yes, this rabbit polyclonal is raised against a large internal region (residues 46–460) that spans both the propeptide and catalytic domains, so it detects pro-MMP-8 and the activated form. Because the epitope is not solely in the propeptide that is cleaved during activation, you will capture both zymogen and mature enzyme. This is advantageous for tracking MMP-8 expression and activation status simultaneously. If you need to distinguish activation state, consider running samples under reducing conditions and comparing band patterns before and after known activators like trypsin or organomercurials in vitro.

What is the recommended starting dilution for Western blot with this MMP-8 antibody?

Start at 1:1000 in blocking buffer, which is the validated dilution for Western blot. MMP-8 is abundant in neutrophils but can be present at low levels in other cell types or tissue extracts. If signal is weak in non-neutrophil samples, try 1:500. Conversely, with purified neutrophils or PMA-stimulated cells, you may achieve cleaner blots at 1:2000. Optimal dilution depends on lysate concentration, membrane type, and detection system sensitivity. Always titrate with your specific sample; include a recombinant MMP-8 standard curve if quantification is planned.

Is this MMP-8 antibody validated for mouse and rat samples?

It is validated for human MMP-8 and predicted to cross-react with mouse, rat, non-human primate, and dog orthologs based on sequence homology in the immunogen region. Mouse MMP-8 shares approximately 78% identity with human, so cross-reactivity is likely but should be confirmed in your hands. We recommend running a positive control—such as LPS-stimulated mouse peritoneal neutrophils or rat bone marrow lysate—alongside your samples. If you observe the expected 75 kDa (pro) and 58–65 kDa (active) bands, the antibody is performing as predicted in that species.

What are suitable positive and negative controls for MMP-8 Western blots?

For positive controls, use freshly isolated human neutrophils, differentiated HL-60 cells, or recombinant human MMP-8. Stimulation with PMA, LPS, or TNF-α for 4–6 hours increases MMP-8 secretion and activation. Gingival crevicular fluid or synovial fluid from inflamed joints also contain high MMP-8 levels. Negative controls include cell lines that do not express MMP-8 (HEK293, many epithelial lines) or neutrophil lysates pre-treated with siRNA knockdown targeting MMP8. Running a lane without primary antibody helps rule out nonspecific secondary binding.

Can this antibody distinguish MMP-8 from other collagenases like MMP-1 or MMP-13?

Yes, this polyclonal is raised against a region unique to MMP-8 and does not cross-react with MMP-1 (interstitial collagenase) or MMP-13 (collagenase-3), which share functional similarity but have distinct sequences outside the conserved catalytic zinc-binding motif. MMP-8 is the predominant collagenase in neutrophils, whereas MMP-1 and MMP-13 are more common in fibroblasts, chondrocytes, and some tumor cells. If your sample contains multiple collagenases, this antibody will selectively detect MMP-8. For additional confidence, compare migration to commercial recombinant standards of each collagenase on the same blot.

How should I store this MMP-8 antibody and what is the expected shelf life?

Store the antibody at –20 °C in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The lyophilized or glycerol-stabilized stock is stable for at least 12 months under these conditions. Once reconstituted or thawed, keep working aliquots at 4 °C for up to one month; add sodium azide (0.02–0.05%) as preservative if storing diluted antibody longer than a week. Do not store diluted antibody in Tris buffers containing primary amines at room temperature. Mark the date on each aliquot and monitor performance over time.

What sample preparation steps optimize MMP-8 detection in tissue lysates?

Lyse tissues in RIPA or similar buffer containing protease inhibitors—critically, omit EDTA or use a minimal concentration, as it chelates zinc and can dissociate MMP-8 from binding partners or alter epitope exposure. Include phosphatase inhibitors if studying regulated secretion. MMP-8 is secreted and often bound to extracellular matrix; brief collagenase digestion or mechanical homogenization improves recovery from fibrous tissues. Clarify lysates by centrifugation at 16,000 g for 10 minutes. Load 20–40 µg total protein per lane; neutrophil-rich samples may require less to avoid overloading.

Western blot validation for RP-MMP8 — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

MMP-8: Hinge region — WB validation
WB · Panel 1 MMP-8: Hinge region
MMP-8: Carboxyterminal end — WB validation
WB · Panel 2 MMP-8: Carboxyterminal end

Custom validation studies available on request — contact us.

Also known as:

  • Neutrophil collagenase
  • Matrix metalloproteinase-8
  • MMP-8
  • PMNL collagenase
  • PMNL-CL
  • EC 3.4.24.34
  • CLG1
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →